Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 3/2011

01-09-2011 | Review Article

Periodontitis and diabetes—a complex relationship

Author: Aparna Ramchandra Gharat

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2011

Login to get access

Abstract

Periodontitis is a common problem in patients with diabetes. The interrelation between diabetes mellitus and inflammatory periodontal disease has been intensively studied for more than 50 years. The relationship between these 2 maladies appears bidirectional—insofar that the presence of one condition tends to promote the other, and that the meticulous management of either may assist treatment of the other. Inflammation plays an important role in this interrelation, orchestrating both the periodontal disease and diabetes mellitus pathogeny and complications. Conversely, periodontal infection can seriously impair metabolic control of some diabetic patients. Moreover, treatment of periodontal disease and reduction of oral signs of inflammation may have a beneficial effect on diabetes. This review examines the relationships that exist between periodontal diseases and diabetes mellitus, with a focus on potential common pathophysiologic pathways including those associated with inflammation, altered host responses and insulin resistance
Literature
1.
Mealey BL. Periodontal disease and diabetes: a two-way street. J Am Dent Assoc. 2006;137:26s–31s.PubMed
2.
Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2003;134:34s–40s.
3.
Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991;26:230–42.PubMedCrossRef
4.
Loe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329.PubMed
5.
Sandholm L, Swanljung O, Rytomaa I, Kaprio E, Maenpaa J. Periodontal status of Finnish adolescents with insulin-dependent diabetes mellitus. J Clin Periodontol. 1989;16:617–20.PubMedCrossRef
6.
Zambon J, Reynolds H, Fisher J, Shlossman M, Dunford R, Genco R. Microbiological and immunological studies of adult periodontitis in patients with noninsulin-dependent diabetes mellitus. J Periodontol. 1988;59:23–31.PubMed
7.
Marder M, Abelson D, Mandel I. Salivary alterations in diabetes mellitus. J Periodontol. 1975;46:567–9.PubMed
8.
Ficara A, Levin M, Grower M. A comparison of the glucose and protein content of gingival fluid from diabetics and nondiabetics. J Periodontal Res. 1975;10:171–5.PubMedCrossRef
9.
Ciancio S, Golub L, Mosovich L, Katz C, Kleinberg I. Urea levels in the gingival crevices of diabetic and normal adolescents. J Dent Res. 1977;56:1144.PubMedCrossRef
10.
Frantzis T, Reeve C, Brown Jr A. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and nondiabetic patients with periodontal disease. J Periodontol. 1971;42:406–11.PubMed
11.
Listgarten M, Ricker Jr F, Laster L, Shapiro J, Cohen DW. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non-diabetics. J Periodontol. 1974;45:676–84.PubMedCrossRef
12.
Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A. 1993;90:6434–8.PubMedCrossRef
13.
Golub L, Garant P, Ramamurthy N. Inflammatory changes in gingival collagen in the alloxan-diabetic rat. J Periodontal Res. 1977;12:402–18.PubMedCrossRef
14.
Golub L, Schneir M, Ramamurthy N. Enhanced collagenase activity in diabetic rat gingival: in vitro and in vivo evidence. J Dent Res. 1978;57:520–5.PubMedCrossRef
15.
Kaplan R, Mulvihil J, Ramamurthy N, Golub L. Gingival collagen metabolism in human diabetics. J Dent Res. 1982;61:275.
16.
Diabetes and periodontal diseases. [Position paper prepared by the research, science and therapy committee of the American Academy of Periodontology]. J Periodontol. 1996;67:166–76
17.
Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol. 1999;71:1313–21.CrossRef
18.
Cutler CW, Shinedling EA, Nunn M, et al. Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol. 1999;70:1429–34.PubMedCrossRef
19.
Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol. 2000;71:1375–80.PubMedCrossRef
20.
Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol. 2001;6:125–37.PubMedCrossRef
21.
Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res. 1981;60:729–30.PubMedCrossRef
22.
Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N. Comparison of neutrophil chemotactic responses in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981;52:410–4.PubMed
23.
Salvi G, Yalda B, Collins J, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol. 1997;68:127–35.PubMed
24.
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycaemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67:1085–93.PubMed
25.
Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol. 1996;23:194–202.PubMedCrossRef
26.
Silvestre F-J, Miralles L, Llambes F, Bautista D, Solá-Izquierdo E, Hernández-Mijares A. Type 1 diabetes mellitus and periodontal disease: relationship to different clinical variables. Med Oral Patol Oral Cir Bucal. 2009;1:E175–9.
27.
Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodgett J, et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of nine cases. J Periodontol. 1992;63:843–8.PubMed
28.
Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997;68:713–9.PubMedCrossRef
29.
Aldridge JP, Lester V, Watts TL, Collins A, Viberti G, Wilson RF. Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. J Clin Periodontol. 1995;22:271–5.PubMedCrossRef
30.
Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001;28:306–10.PubMedCrossRef
31.
Kiran M, Arpak N, Unsal E, Erdoğan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005;32:266–72.PubMedCrossRef
32.
33.
Santos Tunes R, Foss-Freitas MC, Nogueira-Filho GDR. Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc. 2010;76:a35.PubMed
34.
Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes and periodontal infections. J Periodontol. 2005;76:2075–84.PubMedCrossRef
35.
Al-Zahrani MS, Bissada NF, Borawskit EA. Obesity and periodontal disease in young, middle aged and older adults. J Periodontol. 2003;74:610–5.PubMedCrossRef
36.
Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-α in a two-way relationship. J Periodontol. 2003;74:97–102.PubMedCrossRef
37.
Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodgett J, et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontal. 1992;63:843–8.
38.
Faria-Almeida R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontal. 2006;77:591–8.CrossRef
39.
Golub LM, Lee HM, Ryan ME. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998;12:12–26.PubMedCrossRef
40.
Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol. 1996;67 Suppl 10:1094–102.
41.
Mealey BL, Rethman MP. Periodontal disease and diabetes mellitus. Bidirectional relationship. Dent Today. 2003;22:107–13.PubMed
42.
Wijnand JT, Victor EAG, Bruno GL. Effect of periodontal treatment on glycemic control of diabetic patients-A systematic review and meta analysis. Diabetes Care. 2010;33:421–7.CrossRef
Metadata
Title
Periodontitis and diabetes—a complex relationship
Author
Aparna Ramchandra Gharat
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0034-2

Other articles of this Issue 3/2011

International Journal of Diabetes in Developing Countries 3/2011 Go to the issue

Original Article

Prevalence of pre-diabetes and associated risk factors in an adult Omani population

Original Article

Mosaic pancreas or type 3 diabetes: how do we define it?

Original Article

Population-based study of diabetic mellitus prevalence and its associated factors in adult Ghanaians in the greater Accra region

Original Article

Depression in patients with diabetes mellitus and its impact on diabetes self-care, medication adherence and glycemic control

Original Article

Psychological impact of type-1 diabetes mellitus on parents: an exploratory study from North India

Letter to Editor

Simplified management of diabetic ketoacidosis with a novel formula
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits